Local thyroid renin-angiotensin system in experimental breast cancer

M P Carrera-González1, M J Ramírez-Expósito, M D Mayas

  • 1Experimental and Clinical Physiopathology Research Group, Department of Health Sciences, Faculty of Experimental and Health Sciences, University of Jaén, Jaén, Spain.

Life Sciences
|November 2, 2013
PubMed
Abstract

Insights

Breast cancer in rats alters thyroid function by affecting local renin-angiotensin system (RAS) enzymes and hormone production. These changes in thyroid RAS may contribute to dysfunction alongside broader regulatory axis alterations.

Area of Science:

  • Endocrinology
  • Oncology
  • Molecular Biology

Background:

  • The relationship between breast cancer and thyroid dysfunction is established, but mechanisms are unclear.
  • Thyroid hormones influence the renin-angiotensin system (RAS), yet the local RAS role in thyroid function is understudied.

Purpose of the Study:

  • To investigate soluble and membrane-bound RAS-regulating aminopeptidase activities in the thyroid glands of rats with mammary tumors.
  • To examine the correlation between these enzymatic activities and circulating levels of thyroid stimulating hormone (TSH) and free thyroxine (fT4).

Main Methods:

  • Analysis of soluble and membrane-bound RAS-regulating aminopeptidase activities.
  • Fluorometric assay using aminoacyl-β-naphthylamide substrates.

Main Results:

  • Rats with mammary tumors exhibited concurrent alterations in thyroid RAS-regulating enzymes.
  • Thyroid hormone production levels were found to change concomitantly with these enzymatic changes.

Conclusions:

  • Carcinogenesis-induced alterations in local tissue RAS regulatory mechanisms may impact thyroid function.
  • These local RAS changes could act independently or in conjunction with hypothalamic-pituitary axis dysregulation.

Related Concept Videos